Tirzepatide has emerged as a groundbreaking medication for type 2 diabetes, offering promising results. However, the expense of this innovative drug and its access have become key topics for patients and healthcare professionals. While tirzepatide has been approved by regulatory agencies, its high-priced nature presents a significant barrier to ma